Grow your business safely with HAYS PHARMA TECHNOLOGY CONSULTING
All the information you need about HAYS PHARMA TECHNOLOGY CONSULTING to develop and secure your business in France
H
HOME >
CORPORATES
>
HAYS PHARMA TECHNOLOGY CONSULTING >
BALANCE SHEET (
2017-05-04)
THE LIST OF BALANCE SHEET : HAYS PHARMA TECHNOLOGY CONSULTING
| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2019-04-16 | Public | 2018-06-30 | Complete |
| 2018-02-06 | Public | 2017-06-30 | Complete |
| 2017-05-04 | Public | 2016-06-30 | Complete |
| Name | HAYS PHARMA TECHNOLOGY CONSULTING |
| Siren | 821203841 |
| Closing | 2016-06-30 |
| Registry code | 7501 |
| Registration number | 28982 |
| Management number | 2016B14997 |
| Activity code | 7490B |
| Closing date n-1 | 1901-01-01 |
| Duration Fiscal year | 01 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2017-05-04 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 75008 PARIS |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BZ Other receivables | 408.00 | 408.00 | 408.00 | |
CF Cash and cash equivalents | 40 000.00 | 40 000.00 | 40 000.00 | |
CJ TOTAL (II) | 40 408.00 | 40 408.00 | 40 408.00 | |
CO Grand total (0 to V) | 40 408.00 | 40 408.00 | 40 408.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 40 000.00 | 40 000.00 | ||
DI RESULTS FOR THE YEAR (Profit or Loss) | -2 041.00 | -2 041.00 | ||
DL TOTAL (I) | 37 958.00 | 37 958.00 | ||
DX Trade payables and related accounts | 2 449.00 | 2 449.00 | ||
EC TOTAL (IV) | 2 449.00 | 2 449.00 | ||
EE Grand total (I to V) | 40 408.00 | 40 408.00 | ||
EG Accrued income and payables due within one year | 2 449.00 | 2 449.00 | ||
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 2 041.00 | |||
GF Total Operating Expenses (II) | 2 041.00 | |||
GG - OPERATING RESULT (I - II) | -2 041.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -2 041.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 2 041.00 | 2 041.00 | ||
HN PROFIT OR LOSS (Total revenue - Total expenses) | -2 041.00 | -2 041.00 | ||
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
IN DECREASES Start-up, development, or research expenses | 1.00 | 2.00 | 1.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 2 449.00 | 2 449.00 | 2 449.00 | |
VB VAT | 408.00 | 408.00 | ||
VT TOTAL – STATEMENT OF RECEIVABLES | 408.00 | 408.00 | 408.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 2 449.00 | 2 449.00 | 2 449.00 | |
all companies in France
Complete and comprehensive database.
